Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.72 |
| ▸ | MEN1 | O00255 | 2/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.70 |
| ▸ | GAA | P10253 | 4/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | HPGD | P15428 | 2/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | PKM | P14618 | 2/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.64 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mecarbinate SCHEMBL29380431 | 1.00 | LMNA (0.72) | LMNAMEN1KMT2AGAAKDM4E | |
| SCHEMBL22478566 | 0.87 | ALDH1A1 (0.67) | LMNAMEN1KMT2AGAAKDM4E | |
| SCHEMBL6795778 | 0.85 | ALOX5 (0.68) | LMNAMEN1KMT2AGAAKDM4E | |
| SCHEMBL21954348 | 0.84 | ALDH1A1 (0.63) | LMNAMEN1KMT2AGAAKDM4E | |
| SCHEMBL9557007 | 0.83 | SMN1; SMN2 (0.76) | LMNAKDM4ESMN1; SMN2HSD17B10ALDH1A1 | |
| SCHEMBL30875172 | 0.83 | SMN1; SMN2 (0.76) | LMNAKDM4ESMN1; SMN2HSD17B10ALDH1A1 | |
| SCHEMBL30657206 | 0.83 | MEN1 (1.00) | LMNAMEN1KMT2AGAAKDM4E | |
| SCHEMBL6315596 | 0.83 | MEN1 (1.00) | LMNAMEN1KMT2AGAAKDM4E | |
| SCHEMBL13576495 | 0.83 | KMT2A (0.82) | LMNAMEN1KMT2AGAAKDM4E | |
| SCHEMBL29429164 | 0.81 | POLB (0.74) | LMNAMEN1KMT2AGAAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025264604-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2025-12-26 | — | — | WO | claimed |
| US-20250381110-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | PROCTER & GAMBLE (US) | 2025-12-18 | — | — | US | claimed |
| CN-116901484-A | Preparation process of environment-friendly wear-resistant and high-temperature-resistant composite clutch facing | 来安县隆华摩擦材料有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-116515275-A | Chopped glass fiber plastic alloy and preparation method thereof | 安徽捷云新材料科技有限公司 | 2023-08-01 | — | — | CN | claimed |
| CN-116217461-A | Chalcone derivative containing indole structure and preparation method and application thereof | 贵州大学 | 2023-06-06 | — | — | CN | claimed |
| US-20220175742-A1 | COLLAGEN P4H1 INHIBITOR AND ITS USE | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2022-06-09 | — | — | US | claimed |
| CN-111269168-B | Preparation method of arbidol intermediate | 苏州敬业医药化工有限公司 | 2022-04-01 | — | — | CN | claimed |
| WO-2021041942-A1 | COLLAGEN P4H1 INHIBITOR AND ITS USE | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2021-03-04 | — | — | WO | claimed |
| CN-111533677-A | Method for synthesizing arbidol hydrochloride intermediate | 大连万福制药有限公司 | 2020-08-14 | — | — | CN | claimed |
| CN-111269168-A | Preparation method of arbidol intermediate | 苏州敬业医药化工有限公司 | 2020-06-12 | — | — | CN | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| CN-103113287-A | Method for preparing mecarbinate (1,2-dimethyl-5hydroxy-1H-indol-3-ethyl carboxylate) | SHAANXI PUCHENG WANDE SCIENCE & TECHNOLOGY CO LTD | 2013-05-22 | — | — | CN | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| US-12564578-B2 | Collagen P4H1 inhibitor and its use | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2026-03-03 | — | — | US | disclosed |
| US-6264917-B1 | MIXTURE OF GAS FILLED MICROBUBBLES AND RELEASING AGENT | NYCOMED IMAGING AS (NO) | 2001-07-24 | — | — | US | disclosed |
| US-6261537-B1 | TARGETS AND ULTRASOUND DIAGNOSIS OF ACTIVE MATERIALS, AQUEOUS CARRIER LIQUIDS, CARRIERS AND FILM FORMING SURFACTANT PHOSPHATIDES | NYCOMED IMAGING AS (NO) | 2001-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12564578-B2 | Collagen P4H1 inhibitor and its use | P4HA1, P4HTM, COLGALT1 | LMNA 2426/4885MEN1 4242/4885KMT2A 1900/4885 |
| US-20250381110-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | SQSTM1, BECN1, CUTA | LMNA 38/4885MEN1 3254/4885KMT2A 3682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.